Join to View Full Profile
11301 Wilshire BlvdLos Angeles, CA 90073
Phone+1 310-478-3711
Fax+1 310-268-4578
Dr. Pandol is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1978 - 1979
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1975 - 1978
Saint Louis University School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1988
Clinical Trials
- Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer Start of enrollment: 2013 Oct 02
- Online Health Assessment to Support Comprehensive Care Start of enrollment: 2014 May 01
- Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC) Start of enrollment: 2022 May 19
Publications & Presentations
PubMed
- Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters.Richard T Waldron, Ruoxiang Wang, Stephanie N Shishido, Aurelia Lugea, Ahmed G Ibrahim
Cancer Letters. 2025-04-01 - Incidence Trends in Upper Gastrointestinal Cancer in Young Adults: A Nationwide Time-Trend Analysis Using 2001-2019 US Cancer Statistics Databases.Jeff Liang, Ryan Rastegar, Mohamad El Helou, Kushagra Mathur, Brent K Larson
The American Journal of Gastroenterology. 2025-04-01 - Identification of Tumor-Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma.Chen Zhao, Zhili Wang, Hyoyong Kim, Hui Kong, Junseok Lee
Advanced Science. 2025-03-25
Press Mentions
Cedars-Sinai AI Catches Pancreatic Cancer in CT Scans Years in Advance: StudyMay 2nd, 2022- Young Cancer Rates Rising in SAJanuary 23rd, 2022
- New Insights into PancreatitisJanuary 14th, 2021
- Join now to see all
Grant Support
- Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT ImagesCEDARS-SINAI MEDICAL CENTER2021–2026
- Predicting Pancreatic Ductal Adenocarcinoma PDAC Through Artificial Intelligence Analysis of Pre Diagnostic CT Images in African AmericansCEDARS-SINAI MEDICAL CENTER2021–2026
- Role of the ER acetyl CoA transporter in alcoholic pancreatitisUNIVERSITY OF WISCONSIN-MADISON2021–2026
- Predicting Pancreatic Ductal Adenocarcinoma PDAC Through Artificial Intelligence Analysis of Pre Diagnostic CT Images in African AmericansCEDARS-SINAI MEDICAL CENTER2021–2026
- Predicting Pancreatic Ductal Adenocarcinoma PDAC Through Artificial Intelligence Analysis of Pre Diagnostic CT Images in African AmericansCEDARS-SINAI MEDICAL CENTER2021–2026
- A Pilot Clinical Trial of Paricalcitol for Chronic PancreatitisCEDARS-SINAI MEDICAL CENTER2022–2025
- A Pilot Clinical Trial of Paricalcitol for Chronic PancreatitisCEDARS-SINAI MEDICAL CENTER2022–2025
- Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis ConsortiumCEDARS-SINAI MEDICAL CENTER2020–2025
- Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis ConsortiumCEDARS-SINAI MEDICAL CENTER2020–2025
- Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic CancerCEDARS-SINAI MEDICAL CENTER2015–2025
- Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic CancerCEDARS-SINAI MEDICAL CENTER2015–2025
Industry Relationships
- President, Avenzoar PharmaceuticalsFocused on development of novel therapies for cancer2016 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
